Global “Rabies Vaccine” Market industry is anticipated to an extensive growth during the forecast period 2018-2023. Rabies Vaccine Market report provides in detail analysis of market with revenue growth and upcoming trends. report contains the forecasts, market size, share estimates and profiles of the leading industry Players.
Rabies Vaccine Market research report provides derived key statistics, based on the market status of the manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Rabies Vaccine industry. The report is a reliable analysis of current scenario of the market, which covers several market dynamics.
Get a Sample Copy Of The Report At – https://www.absolutereports.com/enquiry/request-sample/13104416
The global rabies vaccine market is expected to register a growth rate of CAGR of 5% during the forecast period, 2018 to 2023. Rabies is a virus which can spread by the bite or scratch of the animal and it can affects both domestic and wild animals. The symptoms of rabies include fever, often pain or unusual tingling sensation around the wound. According to the key facts published by World Health Organization (WHO) 59,000 people die of rabies each year and 95% of human rabies cases occur in Asia and Africa. Government is also taking initiatives towards rabies-free world, for instance United Against Rabies, a collaboration of four partners consisting of World Health Organization (WHO), Food and Agriculture Organization of the United Nations (FAO), World Organization for Animal Health (OIE) and Global Alliance for Rabies Control (GARC) developed a global strategic plan (Zero by 30) to achieve zero rabies human deaths.
Rise in Incidences of Animal Bite to Propel the Rabies Vaccine Market
The animal bites are the significant cause of the morbidity and mortality. According to the estimates of World Health Organization (WHO) in the US approximately 4.5 million people are bitten by dogs every year. The dog bite fatality rate is high in low and middle income countries as compared to high income countries However, 55 000 people die annually from rabies, and bites from rabid dogs account for the vast majority of these deaths. Thus, the rise in incidences of animal bite to propel growth of the market over the forecast period.
Other factors driving growth of this market are the low immunization rates in pets and growing number of stray animals in developing countries.
Rising Maintenance Costs for Storage of Vaccines to Restrain Growth of the Rabies Vaccine Market
The instability and rising maintenance cost of vaccines is the major restrain for the rabies vaccine market. The cold supply chain of vaccine consist of different levels called tiers, this tiers plays different functions in supply chain of vaccines. There are two main functions that are considered in the costing tool such as storage function and the distribution/transportation function. In this two functions the cost can be divided into labor, cold chain equipment, cold chain recurrent costs (energy and maintenance), vehicles, and storage space. The cost associated with storage and transportation of vaccine is huge. Thus, the rising maintenance cost of vaccine during storage and transportation expected to restrain growth of the market over the forecast period.
Other factor restraining growth of the market includes lack of knowledge about preventive measures amongst the population.
North America to Dominate Rabies Vaccine Market
North America dominates the global rabies vaccine market owing to the rising adoption of companion animals, increasing pet healthcare insurance, and improved veterinary healthcare infrastructure. According to the estimates of American Society for the Prevention of Cruelty to Animals (ASPCA) every year approximately 6.5 million companion animals enter in the US animal shelters nationwide. Thus, the rising population of animals is expected to drive growth of the market over the forecast period. In addition, government authorities such as WHO, One Health Commission and World Organization for Animal Health (OIE), amongst others are taking initiatives to make the world rabies free.
Key Developments in the Market
• Oct 2017 – Biopharma and Kamada Ltd., two leading human-derived protein therapeutics companies, announced that KEDRAB [Rabies Immune Globulin (Human)] has been launched in the US and initial shipments are now reaching healthcare practitioners across the country.
Major Players – CADILA PHARMACEUTICALS, CSC PHARMACEUTICALS INTERNATIONAL, CHANGCHUN BCHT BIOTECHNOLOGY CO. LTD., GSK GROUP OF COMPANIES, MERIAL (PART OF BOEHRINGER INGELHEIM), MERCK & CO., INC., SANOFI PASTEUR, INC., SERUM INSTITUTE OF INDIA PVT. LTD., and CRUCELL (JANSSEN GLOBAL SERVICES, LLC) among others.
Major Regions: – US,Canada, UK, Germany, France, China, Japan, India
Inquire Or Share Your Questions If Any Before The Purchasing This Report –https://www.absolutereports.com/enquiry/pre-order-enquiry/13104416
Reasons to Purchase this Report:
- Analysing various perspectives of the Rabies Vaccine market size with the help of Porter’s five forces analysis.
- Study on the product type that is expected to dominate the market.
- Study on the regions that are expected to witness fastest Rabies Vaccine market growth during the forecast period.
- Identify the latest developments, Rabies Vaccine market shares and strategies employed by the major market players.
- 3 months’ analyst support along with the Market Estimate sheet (in excel).
Major Points Covered in Table of Content of Rabies Vaccine Market forecast 2023
1. Introduction of Rabies Vaccine Market Report
1.1 Study Deliverables
1.2 General Study Assumptions
2. Research Methodology
2.2 Analysis Methodology
2.3 Study Phases
2.4 Econometric Modelling
3. Executive Summary
4. Market Overview and Rabies Vaccine Market Trends
4.2 Market Trends
4.3 Porter’s Five Force Framework
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Consumers
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitute Products and Services
4.3.5 Competitive Rivalry within the Industry
5. Rabies Vaccine Market Dynamics
6. Global Rabies Vaccine Market, Segmented by Size
7. Global Rabies Vaccine Market, Segmented by Technology Type
Purchase This Report (Price 4250 USD for single user license) – https://www.absolutereports.com/purchase/13104416
8. Global Rabies Vaccine Market, Segmented by Geography
8.1 North America
8.1.1 United States
8.2 South America
8.4.1 United Kingdom
8.5 Africa and Middle East
8.5.2 South Africa
8.5.3 Saudi Arabia
9. Competitive Landscape
9.2 Market Share Analysis
9.3 Developments of Key Players
10. Key Vendor Analysis (Overview, Products & Services, Strategies)
11. Future Outlook of the Market
And Many More……….
About Absolute Reports:
Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.
Name: Ajay More
Email: [email protected]
Organization: Absolute Reports
Phone: +14242530807/+44203239 8187